NON-PROLIFERATIVE DIABETIC RETINOPATHY
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drug shows promise for diabetic vision loss
Disease control CompletedThis study tested a drug called faricimab in 179 people with non-proliferative diabetic retinopathy, a condition where diabetes damages blood vessels in the eye. The goal was to see if the drug could improve blood flow to the retina over 48 weeks. Participants received either mon…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Greater Houston Retina Research • Aim: Disease control
Last updated May 17, 2026 15:09 UTC
-
New combo therapy shows promise for diabetic eye damage
Disease control CompletedThis study tested whether adding a second drug (B55R2) to a standard treatment (B55R1) works better for people with non-proliferative diabetic retinopathy, a common eye problem from diabetes. 52 adults with mild to severe disease received either the combo or the single drug for 2…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE4 • Sponsor: AJU Pharm Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC